Analytics
- Ref-No.Technology
- 01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
- 01-01011Biphasic, copolymeric, stretchable membrane and bioreactor for investigating cells at the air liquid interface (ALI)
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 03-00459
Autofocus-control of a microscope including an electrically tunable lens
- 03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
- 06-00053Cost-efficient Disposable Filtration Microtiter Plates for High Throughput Applications
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 15-00461
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
- 15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00071A scalable and highly sensitive assay for measuring extracellular NAD+ level in human body fluids
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 99-00160
E-Morph Assay – an innovative image-based phenotypic screening assay for estrogenic and anti-estrogenic activity
Animal Models
- Ref-No.Technology
- 002249B10.129S2(B6)-Igh-6tm1Cgn/J
- 002250B10.129P2(B6)-Il10tm1Cgn/J
- 002251B6.129P2-Il10tm1Cgn/J
- 002253B6.129P2-Il4tm1Cgn/J
- 002288B6.129S2-Igh-6tm1Cgn/J
- 002397129-Cd5tm1Cgn/J
- 002399129-Igh-5tm1Cgn/J
- 002400C57BL/6-Igk-Ctm1Cgn/J
- 002401B6.129S2-Igll1tm1Cgn/J
- 002405B6.129P2-Ncam1tm1Cgn/J
- 002438B6.129P2-Igh-Jtm1Cgn/J
- 002479STOCK Il2rgtm1Cgn/J
- 002527STOCK Tg(Mx1-cre)1Cgn/J
- 002538C.129P2(B6)-Igh-5tm1Cgn/J
- 002858STOCK Tg(balancer1)2Cgn/J
- 002859STOCK Tg(balancer2)3Cgn/J
- 002965C57BL/6-Itgb7tm1Cgn/J
- 003465BALB/c-Tg(CMV-cre)1Cgn/J
- 003556B6.Cg-Tg(Mx1-cre)1Cgn/J
- 003968C3Bir.129P2(B6)-Il10tm1Cgn/J
- 004126C.129P2-Cd19tm1(cre)Cgn/J
- 004192STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J
- 004222NOD.129P2(B6)-Il4tm1Cgn/DvsJ
- 004254NOD.Cg-Igh-6tm1Cgn Tg(IghelMD4)4Ccg/Dvs
- 004266NOD.Cg-Il10tm1Cgn/DvsJ
- 004291NOD.Cg-Il10tm1Cgn Il4tm1Cgn/DvsJ
- 004326C3Bir.129P2(B6)-Il10tm1Cgn/Lt
- 004333C.129P2(B6)-Il10tm1Cgn/J
- 004349C.129S2-Igh-6tm1Cgn/J
- 004368129-Il10tm1Cgn/J
- 004639NOD.129S2(B6)-Igh-6tm1Cgn/DoiJ
- 004781B6.129P2-Lyzstm1(cre)Ifo/J
- 004943NOD.Cg-Selltm1Tft Itgb7tm1Cgn/LtJ
- 004944NOD.B6-Itgb7tm1Cgn/2Lt
- 004982C3Bir.Cg-Il10tm1Cgn (D3Mit11-D3Mit19)/Lt
- 005306NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ
- 005309NODCaj.Cg-Igh-6tm1Cgn Tg(Igh-VB1-8/Igh-6)2Mjsk/FswJ
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
- 03-00144
Mice with Kidney-specific Megalin Gene Defect
- 03-00145
Kinin B1 Receptor Knock-Out Mice
- 03-00184
Double-Transgenic Rats as a Tool to Study the Function of the Renin-Angiotensin System
- 03-00188
Tryptophan Hydroxylase 1 Knockout Mice as a Tool to Study the Function of Serotonin
- 03-00189
TGR(hKLK1) Transgenic rats as a Tool to Study the Kallikrein-Kinin System
- 03-00190
Angiotensinogen Transgenic Mice TGM(rAOGEN)123
- 03-00202
Renin Transgenic Rat TGR(mREN2)27
- 03-00238
Conductin+/lacZ-mice as a model for Wnt-mediated tumorigenesis
- 03-00244
CCR7 -/- mice: a model for studies on early immune reponses towards alloantigens
- 03-00249
SLP3 mutant mice; an animal model lacking touch-evoked neuropathic pain
- 03-00300
Animal model for endotoxic shock: transgenic rats with endothelial overexpression of kinin B1 receptors
- 03-00495
A titin-DsRed knock-in mouse model to study cardiac and skeletal muscle disorders
- 03-00504
A titin-eGFP knock-in mouse model to study cardiac and skeletal muscle disorders
- 11-00041PARP1 -/- mice: an animal model for cancer, autoimmune encephalomyelitis, arthritis and diabetes
- 11-00046GFP Transgenic Zebrafish strain as tool for studying kidney development
- 11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
- 15-00379
Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 21-00013aMAG -/- mice: a model for studying pathological mechanisms of acquired demyelinating diseases
- 21-00013bTenascin-R knock-out mice
- 21-00013cCHL1 -/- mice: a model for studying the function of the close homologue of adhesion molecule L1
- 43-00017
SCON – Artificial intron devoid of hypomorphic target gene effects for one-step generation of conditional animal models
Antibodies
- Ref-No.Technology
- 03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00515
HDLBP overexpression enhances protein production and secretion
- 10-00064Highly-sensitive, highly-specific recombinant BMP-2 and BMP-14 antibodies
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 18-00052
Broadly neutralizing antibodies against hepatitis E virus (HEV)
Contactin1, mouse/chicken, mouse monoclonal
- 17beta-HSDcl
- ACP33 acidic cluster protein 33, ligand of CD4
- ActA purified, several epitopes
- Activation-induced cytidine deaminase (AID)
- Adenovirus type 5, E1B-55 kDa
- Adenovirus type 5, E4orf3
- Adenovirus type 5, L4-100 kDa
- Ago 1
- Ago 2
- APRIL
- APRIL-Phosphothreonin 224
- Blocking, FC gamma receptor, mouse, several isotypes
- Bop1 (human, block of proliferation)
- Borna gp18
- Borna p24
- Borna p40
- Borna p56
- BRD7, human, cellular
- C-24
- C-Myc, N-term
- C1q, C3, C4, mouse
- C1q, human
- Calcitonin
- Canine, CD44
- CBF1 (CSL, Su(H), RBP-1)
- CCR9
- CD154, human, monkey
- CD155
- CD3 epsilon chain
- CD4, mouse
- CD44, canine
- CD49c
- CD8, mouse
- CD83, human
- CD96
- Cdc45 cell division cycle 45p
- CDs, several, dog
- CDs, several, dog
- Cellular, BRD7, human
- Chicken, GTP cyclohydrolase
- Chicken, Interferon -γ
- Chicken, Interferon, alpha
- Chimerin
- CNG channel alpha3, rat
- CNG channel, cone type, rat
- Cyclodextrinase, Klebsiella oxytoca
- Cythohesin-1
- CYTIP
- Cytomegalievirus, glycoprotein gp40
- Dead box protein, DP103
- Dead box protein, DP103
- DLL1
- DNA pol delta p125 subunit
- DNA pol delta p50 subunit
- dog C1q
- Dog, several CDs
- Dog, several CDs
- DUTPase, EBV
- dUTPase, human
- E1B AP5 / HNRPUL1, Ribonucleoprotein hnRNP
- EBNA-3A
- EBV, BHRF1
- EBV, dUTPase
- EBV, EBNA1
- EBV, EBNA2, several epitopes
- EBV, EBNA2, wwp-peptide
- EBV, EBNA2A, several epitopes
- EBV, EBNA2b, several epitopes
- EBV, LMP1, several epitopes
- EBV, LMP2a, TP, several epitopes
- EDG
- ENV, Herv K10
- ENV, Herv K10
- ENV, Herv K10
- Epitopes, several, HIV-2, Nef protein
- Epsilon chain, Protein kinase C
- FC gamma receptor, mouse, blocking, several isotypes
- FITC
- FLT-1
- Formin-related protein in leukocytes 1
- Gag protein, Herv K10
- GTP cyclohydrolase, chicken
- GTP cyclohydrolase, human
- GTP cyclohydrolase, murine
- Guanylate binding protein GBP-1
- H2BUb1 (histone2B, ubiquintylated)
- H3X
- HCMV, US28
- Helt
- Herv K10, ENV
- Herv K10, ENV
- Herv K10, ENV
- Herv K10, gag protein
- HHV8, Kaposin
- HHV8, majorcapsid antigen (OFR 25)
- HHV8, minor capsid antigen (ORF 26)
- HHV8m, dUTPase
- Histone H3, K27 dimethylated
- Histone H4, K20 methylated
- HIV-2, Nef protein, several epitopes
- Hmd, Methanothermobacter
- Hmd, Methanothermobacter
- HSP72
- Human cellular, USP7/HAUSP
- Human origin recognition complex, OCR1 (hsORC)
- Human origin recognition complex, OCR2 (hsORC)
- Human origin recognition complex, OCR6 (hsORC)
- Human origin recognition complexOCR3 (hsORC)
- Human, C1q
- Human, CD154, monkey
- Human, cellular, BRD7
- Human, GTP cyclohydrolase
- Human, Importin a1
- Human, Importin a3
- Human, Importin a4
- Human, Importin a5
- Human, Importin a7
- Human, Methyltrans-ferase PRMT2
- Human, Notch1 intracellular, mouse
- Human, Notch3, intracellular
- Human, PAX9, murine
- Human, primase, p58, p48
- Human, Replication protein A, RPA32
- Human, Replication protein A, RPA70
- Hyperpolarization-activated Channel HCN1
- Hyperpolarization-activated channel HCN2
- Hyperpolarization-activated channel HCN3
- Hyperpolarization-activated channel HCN4
- Id, mouse lymphoma
- IgG2c, rat
- Ink4a
- Interferon alpha, chicken
- Isotypes, several, FC gamma receptor, mouse, blocking
- Isotypes, various, murine CD45
- Jul 1C11
- K20 methylated, Histone H4
- Kaposin, HHV8
- Karyopherin alpha2, Rch1
- Lambda light chain, rat
- LARK
- LARK/RBM4A
- LCMV-gp44 (Klon 25)
- Listeria monocytogenes Internalin B, Dhly pfrA 7973
- Listeria supernatant EDGprfA+
- Listeria supernatant EDGprfA+
- Listeria supernatant, complete
- Listeria supernatant, electro-elualed bands
- Listeria supernatant, eletro-elualed bands
- Ly1.1, Mouse anti mouse CD5
- Ly1.2, Mouse anti mouse CD5
- Lyt-1, mouse
- M161Ag
- MAD1
- Mage11
- MBP, maltose-binding protein, rat
- Methanothermobacter, Hmd
- Methanothermobacter, Hmd
- Methyltransferase PRMT2, human
- Monkey, human, CD154
- Motifantibody Poly DE
- Motifantibody Poly PRO
- Mouse anti mouse CD5, Ly1.1
- Mouse anti mouse CD5, Ly1.2
- Mouse anti-MBP, maltose binding protein
- Mouse anti-TrpE
- Mouse IRS-2
- Mouse IRS-2
- Mouse lymphoma, ld
- Mouse Lyt-1
- Mouse, C1q, C3, C4
- Mouse, CD4
- Mouse, CD8
- Mouse, RmT1, RmT2, RmT5, anti-Thy1
- Mouse, several Isotypes, FC gamma receptor, blocking
- Mouse, Thy1.2, spleen AKR
- Mouse, Thy1.2, spleen CBL
- Murine CD45, various isotypes
- Murine, GTP cyclohydrolase
- Murine, PAX9, human
- N-term, C-Myc
- NCAM AB – 5A2
- Nef protein, several epitopes, HIV-2
- Notch1 intracellular, mouse, human
- Notch3, intracellular, human
- OCR1, human origin recognition complex (hsORC)
- OCR2, human origin recognition complex (hsORC)
- OCR3, human origin recognition complex (hsORC)
- OCR6, human origin recognition complex (hsORC)
- PAX1
- PAX9, murine, human
- PAY, PC2 associated Q-rich protein
- PCNA
- Pes1 (human, pescadillo, rRNA processing factor)
- PF1
- PF63.1
- Pirin
- PP32
- Primase, p58, p48, human
- Protein kinase C, epsilon chain
- Protein kinase C, zeta chain
- Protein phosphatase 2A
- Rat anti-GST, synergistic to M-GST
- Rat anti-trpE
- Rat IgG2c
- Rat, lambda light chain
- Rat, MBP, maltose-binding protein
- RBM4A
- RBM4B
- RBM4B
- RBP (CBF1)
- Rch1, Karyopherin alpha2
- Replication protein A, RPA14
- Replication protein A, RPA32, human
- Replication protein A, RPA70, human
- Ribonucleoprotein hnRNP, E1B AP5 / HNRPUL1
- RISP
- RmT1, RmT2, RmT5, anti-Thy1, mouse
- RNA Polymerase II - CTD (non-phosporylated)
- RNA Polymerase II - CTD-Ser2-P
- RNA Polymerase II - CTD-Ser5-P
- RNA Polymerase II - CTD-Ser7-P
- RNA Polymerase II - CTD-Thr4-P
- RNA Polymerase II - CTD-Tyr1-P
- Sepiapterin reductase
- SH2D1A (X-linked lymphoproliferative disease XLP)
- TCR
- Tenascin-R
- Thy1.2, mouse, spleen AKR
- Thy1.2, mouse, spleen CBL
- TMEM59
- TRAF1
- TRAF2
- Transcription Cofactor NC2 alpha
- TrpE, Rat
- US28, HCMV
- USP7/HAUSP, human cellular
- UTP18 (human, rRNA processing factor)
- VIII41, ZBP-89
- WDR12 (WD-repeat 12, rRNA processing factor)
- wwp-peptide, EBV, EBNA2
- Yku70, yeast
- Zeta chain, Protein kinase C
Cardiovascular
- Ref-No.Technology
- 03-00303
RBM20 as a diagnostic marker for cardiovascular diseases
- 03-00319
Stimulation of arteriogenesis for the prevention of myocardial infarction
- 03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 15-00371
lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00411
Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
- 15-00433
Bioartificial vascular grafts based on a highly compacted acellular fibrin matrix
- 15-00551
Automated production of cardiac organoids
- 32-00049
Recombinant uromodulin to prevent vascular calcification in chronic kidney disease
- 32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
- 32-00106
High Performance Paclitaxel-Coated Balloon Catheters
Chemical Catalyst
Chemical Synthesis
CNS
- Ref-No.Technology
- 01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
- 01-00987
DMD Gene Therapy Approach
- 01-01015
AAV-based split-dCas9 gene activator system for in vivo reprogramming approaches
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 03-00363
Small molecule inhibitors of STOML3 promise to treat neuropathic pain
- 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
- 03-00466
Selective iNOS small molecule inhibitors for the prevention of NO-dependent neuroinflammation
- 03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
- 03-00493Novel Self-Organizing 3D Human Neuromuscular Organoids
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 15-00247
Methylation biomarker to predict the response to monoaminergic antidepressants
- 21-00011
Radiopharmaceutical for low-cost and high-sensitivity diagnosis of early-stage dementia and tissue viability in acute stroke.
- 21-00019
Microelectrode array with combined optical stimulation
- 21-00027
Ferulic acid derivatives as efficient neuroprotective agent and memory enhancer
- 23-00054
Vinpocetine inhibiting PDE1, a target for disease modifying therapy of synucleinopathies like multiple system atrophy (MSA)
- 23-00064Treating dementia and other brain disorders with natural glycans
- 23-00065Novel treatment of dementia-associated tauopathies
- 23-00069
NMDAR targeted CAAR-T cell therapy
- 23-00074Treating C9orf72 ALS/FTD with active vaccination
- 23-00075
HERV inhibitors for use in tauopathies
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
COVID-19 Related Technologies
- Ref-No.Technology
- 01-01011Biphasic, copolymeric, stretchable membrane and bioreactor for investigating cells at the air liquid interface (ALI)
- 01-01024
CRISPR/Cas13-based approach for the treatment of viral diseases caused by RNA viruses
- 01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00377Low Bandwidth Data Base Synchronization – LBDS
- 02-00405
TRSbait – RNA-mimicry of viral transcription regulator as
antiviral drug - 03-00461
Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
- 07-00080Innovative plasmids and cells for SARS-CoV-2-specific research
- 14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
- 32-00135
Novel broad spectrum SARS-CoV-2 Vaccine Gene
- 43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
Dermatology
- Ref-No.Technology
- 01-00970Skin Tissue Model “SCAR-In-A-Dish”
- 03-00363
Small molecule inhibitors of STOML3 promise to treat neuropathic pain
- 03-00454
ACE2 Inhibitors for therapy of inflammatory skin diseases and stimulation of pigmentation
- 14-00097
Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097
Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 32-00091
Particle-mediated transport of dissolved active agents into hair follicles enhance delivery to and penetration in the skin
- 42-00047
Tyrolian algae extract with anti-inflammatory potential
Diagnostics
- Ref-No.Technology
- 01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00328Determination of Biofilm Dynamics via Impedance
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00353
High-throughput Screening for anti-herpesviridae Drugs
- 02-00375CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00396
Novel lectin-targeting conjugates for treatment or diagnosis of bacterial infections
- 02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
- 03-00303
RBM20 as a diagnostic marker for cardiovascular diseases
- 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
- 03-00448
Method and kit for early detection of preeclampsia
- 03-00459
Autofocus-control of a microscope including an electrically tunable lens
- 03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
- 03-00470
FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
- 03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 14-00128
Blood-based tuberculosis precision medicine: transcriptomic model shortens therapy duration
- 14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
- 14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
- 14-00169
Blood-based tuberculosis precision medicine: transcriptomic model predicts treatment response
- 14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
- 15-00247
Methylation biomarker to predict the response to monoaminergic antidepressants
- 15-00371
lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00411
Novel diagnostic for Peripartum cardiomyopathy (PPCM) in pregnant women
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
- 15-00523
Novel Diagnostic for Hepatitis
- 15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
- 15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
- 21-00011
Radiopharmaceutical for low-cost and high-sensitivity diagnosis of early-stage dementia and tissue viability in acute stroke.
- 23-00046
microRNA Signature Indicates Risk for Cognitive Decline
- 32-00056
Non-invasive measurement of myocardial power
- 32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
- 42-00019Fungal multiplex genetic engineering exploiting the pyrimidine salvage pathway
- 43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
- 44-00014
Unconventional T cell population as blood marker for Crohn's disease
- 99-00136
TFAM-TFB2M interaction assay for assessment of organ dysfunction in sepsis
Drug Delivery
- Ref-No.Technology
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00369
Biodynamers enhance drug delivery
- 02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 32-00091
Particle-mediated transport of dissolved active agents into hair follicles enhance delivery to and penetration in the skin
- 99-00075
DNA hydrogels from linear building blocks
Gastroenterology
- Ref-No.Technology
- 03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 11-00065
Nutritional compositions for treating dysfunction of liver fat metabolism – VAFD
- 15-00436MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
- 15-00446
Liver stem cell generation for therapeutic applications
- 15-00523
Novel Diagnostic for Hepatitis
- 18-00052
Broadly neutralizing antibodies against hepatitis E virus (HEV)
- 44-00014
Unconventional T cell population as blood marker for Crohn's disease
Gene Therapy
- Ref-No.Technology
- 01-00987
DMD Gene Therapy Approach
- 01-01015
AAV-based split-dCas9 gene activator system for in vivo reprogramming approaches
- 03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 15-00446
Liver stem cell generation for therapeutic applications
- 32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
- 32-00082
Reprogramming immune cells to develop allogenic CAR cell-based therapies
- 32-00083
CRISPR-Cas induced immunosuppressant resistance in anti-viral T cell products for clinical application
- 32-00101
High-level recombinant adeno-associated virus production
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
Gene Therapy Tools
- Ref-No.Technology
- 01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
- 01-01015
AAV-based split-dCas9 gene activator system for in vivo reprogramming approaches
- 01-01024
CRISPR/Cas13-based approach for the treatment of viral diseases caused by RNA viruses
- 01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
- 02-00369
Biodynamers enhance drug delivery
- 03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
- 03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00453
Homology Independent Genomic Sequence Replacement
- 03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
- 03-00539Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 03-00541
Safer Sleeping Beauty transposase variants with improved integration profiles (away from exons)
- 03-00542
Activity-enhanced variant of hyeractive Sleeping Beauty transposase SB100X
- 15-00728
Non-integrating alpharetrovirus-based vector particles for efficient RNA delivery and targeted gene modification
- 15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
- 32-00082
Reprogramming immune cells to develop allogenic CAR cell-based therapies
- 32-00083
CRISPR-Cas induced immunosuppressant resistance in anti-viral T cell products for clinical application
- 32-00101
High-level recombinant adeno-associated virus production
- 32-00124
TCR/CD3-specific CAR NK-92 cells for purification of TCR-modified T cell products
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
- 43-00004
CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient and safer CRISPR/Cas9 genome editing
- 43-00013
CRISPR StAR: sgRNA expression vectors for reliable and reproducible in vivo screenings
Green Biotech
- Ref-No.Technology
- 06-00002Plant Virus Resistance
- 06-00059Epidermis-specific pathogen-inducible promoter for cereals
- 10-00106Gramibactin - A Novel Bifunctional Siderophore-NO-Donor for application in agriculture
- 42-00019Fungal multiplex genetic engineering exploiting the pyrimidine salvage pathway
- 99-00108
Triggering of plant immunity through bacterial hydroxy fatty acid metabolites
Immunology/Autoimmune
- Ref-No.Technology
- 01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 02-00330Mouse models for liver immunity and therapeutic vaccinations
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00399/32-00019
Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00417
Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00454
ACE2 Inhibitors for therapy of inflammatory skin diseases and stimulation of pigmentation
- 03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
- 03-00539Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 14-00097
Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097
Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
- 14-00173
Replacement of allergen challenge: Safely scoring prevalence & severity of allergies
- 15-00379
Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 15-00461
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
- 15-00523
Novel Diagnostic for Hepatitis
- 15-00611Engineered Immune Cells to Specifically Eliminate Undesired Immune Responses
- 15-00740
Maintenance of regulatory T cell phenotype by expression of IL-2 fusion protein
- 22-00009Quiescent B Cells for immune suppression in gene therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 23-00069
NMDAR targeted CAAR-T cell therapy
- 32-00049
Recombinant uromodulin to prevent vascular calcification in chronic kidney disease
- 32-00124
TCR/CD3-specific CAR NK-92 cells for purification of TCR-modified T cell products
- 43-00013
CRISPR StAR: sgRNA expression vectors for reliable and reproducible in vivo screenings
- 44-00014
Unconventional T cell population as blood marker for Crohn's disease
Infectious Diseases
- Ref-No.Technology
- 01-01011Biphasic, copolymeric, stretchable membrane and bioreactor for investigating cells at the air liquid interface (ALI)
- 01-01024
CRISPR/Cas13-based approach for the treatment of viral diseases caused by RNA viruses
- 01-01030
Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)
- 02-00303Novel Myxopyronin Analogues and Myxopyronin Genecluster for Mutasynthesis
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
- 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
- 02-00324Innovative DOTA-Linkers for Bacterial Targeting
- 02-00328Determination of Biofilm Dynamics via Impedance
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
- 02-00337Novel labyrinthopeptins as anti-viral agents
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00353
High-throughput Screening for anti-herpesviridae Drugs
- 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
- 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
- 02-00373Highly potent small molecules prevent tissue damage following S. aureus infection by inhibiting α-hemolysin
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00375CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs
- 02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 02-00378
Overcoming resistance - Novel inhibitors of virulence factor LasB of Pseudomonas aeruginosa
- 02-00387
Novel Darobactin Derivatives - highly active antibacterials against gram-negative bacteria
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00396
Novel lectin-targeting conjugates for treatment or diagnosis of bacterial infections
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
- 02-00402
Novel Inhibitors of Cytomegalovirus
- 02-00405
TRSbait – RNA-mimicry of viral transcription regulator as
antiviral drug - 02-00413
Rapid Detection of Shiga toxin producing E.coli (STEC)
- 10-00026Novel Benzothiazinones, potent Tuberculosis antibiotics
- 10-00087Jagaricin – a novel antifungal natural compound
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 14-00020
Anti-inflammatory, LPS-neutralizing and anti-bacterial agent against sepsis and other severe bacterial infections
- 14-00020bSALP peptides are potent broad-spectrum anti-viral agents
- 14-00097
Anti-inflammatory, anti-bacterial agent for treatment of Atopic Dermatitis
- 14-00097
Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 14-00098
Targeting host lipid homeostasis to augment anti-mycobacterial treatment
- 14-00128
Blood-based tuberculosis precision medicine: transcriptomic model shortens therapy duration
- 14-00169
Blood-based tuberculosis precision medicine: transcriptomic model predicts treatment response
- 14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
- 15-00461
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
- 18-00050
Lonafarnib inhibits cell entry of Human Respiratory Syncytial Virus (hRSV)
- 18-00052
Broadly neutralizing antibodies against hepatitis E virus (HEV)
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 32-00135
Novel broad spectrum SARS-CoV-2 Vaccine Gene
- 43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
- 44-00013
Keratinophile photosensitizers for safe and rapid treatment of onychomycosis
Medical Devices
- Ref-No.Technology
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 03-00459
Autofocus-control of a microscope including an electrically tunable lens
- 15-00199The “i-scoop” – a new type of laryngoscope for normal and difficult airways
- 15-00384Pre-sterilized modular surgical guidance device
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00433
Bioartificial vascular grafts based on a highly compacted acellular fibrin matrix
- 15-00490
Irradiation device and method for optical cochlear implants and laser surgery sytems
- 15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
- 15-00577Effective prevention of biofilm-associated infections on dental implants
- 21-00019
Microelectrode array with combined optical stimulation
- 21-00032
“Multiplextrode” – a completely novel electrode for analogue multiplexing
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00056
Non-invasive measurement of myocardial power
- 32-00058Blood transfusion safety system Cairos
- 32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
- 32-00082
Reprogramming immune cells to develop allogenic CAR cell-based therapies
- 32-00106
High Performance Paclitaxel-Coated Balloon Catheters
- 32-00108
Fiber Membrane Oxygenator with Minimized Priming Volume
- 42-00036
Novel gas flow system for high throughput determination of oxygen dissociation curves (ODC)
- 99-00075
DNA hydrogels from linear building blocks
- 99-00153
Ultra-thin imaging fiber endoscope using a diffuser as encoder and a deep neural network as decoder
- 99-00169
Anti-fouling and cell-adhesion resistant surface coating for medical implants
Metabolic Diseases
- Ref-No.Technology
- 01-00901
Marker for beta-cell maturation
- 01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
- 03-00248
MAS-G-Protein-coupled receptor agonists for the treatment of the metabolic syndrome
- 03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 15-00379
Mutation leading to Type 1 Diabetes mellitus and corresponding animal model
- 32-00049
Recombinant uromodulin to prevent vascular calcification in chronic kidney disease
Oncology
- Ref-No.Technology
- 01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
- 01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
- 01-01042
IDC-like 3D mammary organoids derived from healthy primary luminal cells with invasive potential
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 01-01080
Drug combinations to overcome therapy resistance in cancer
- 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
- 03-00352
Repurposing Niclosamide for (neo-)adjuvant cancer therapy
- 03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00417
Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00430
Selective Inhibitors of Genotoxic Stress Induced IKK/NFκB Pathways for Cancer Therapy
- 03-00475
Novel combination of inhibitors of WNT and MACC1 for cancer therapy
- 03-00539Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00135
Epigenetic detection of early-stage non-small cell lung cancer in blood
- 14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
- 15-00371
lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00502
Predicting the therapeutic effect of compositions containing BH3 mimetics
- 15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00604
Novel Diagnostic Marker For Early Detection Of Bladder Cancer
- 15-00612TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
- 15-00751
Prediction of L-Asparaginase resistance in tumor therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 32-00059
T-cell therapy of MYD88L265P-dependent B-cell lymphoma
- 32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
- 32-00124
TCR/CD3-specific CAR NK-92 cells for purification of TCR-modified T cell products
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 42-00040
Otviciclib - a new pan-CDK inhibitor in oncology
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
- 43-00013
CRISPR StAR: sgRNA expression vectors for reliable and reproducible in vivo screenings
- 43-00016
SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput
- 49-00012
A novel approach for acute leukocyte mobilization from the bone marrow
- 99-00160
E-Morph Assay – an innovative image-based phenotypic screening assay for estrogenic and anti-estrogenic activity
Other Indications
- Ref-No.Technology
- 02-00412
ChemLM: a chemical LLM for molecular property prediction of experimental compounds
- 03-00399/32-00019
Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00466
Selective iNOS small molecule inhibitors for the prevention of NO-dependent neuroinflammation
- 03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
- 03-00493Novel Self-Organizing 3D Human Neuromuscular Organoids
- 10-00107Barnesins – novel natural small molecules as highly specific cysteine protease inhibitors
- 11-00060
Novel treatment or prevention of age-related diseases extending lifespan
- 11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
- 15-00154Novel method for serum-free generation of respiratory epithelial cells
- 15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00555
Method for high-yield production of megakaryocytes
- 15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00082
Reprogramming immune cells to develop allogenic CAR cell-based therapies
- 42-00019Fungal multiplex genetic engineering exploiting the pyrimidine salvage pathway
- 42-00047
Tyrolian algae extract with anti-inflammatory potential
- 49-00012
A novel approach for acute leukocyte mobilization from the bone marrow
Research Tools
- Ref-No.Technology
- 01-00366Human Voxel Models
- 01-00901
Marker for beta-cell maturation
- 01-00940
Mammary organoids derived from primary human breast epithelial cells
- 01-00970Skin Tissue Model “SCAR-In-A-Dish”
- 01-00986
Non-invasive and high-throughput monitoring of exon-specific isoform expression
- 01-00988
INSPECT - Intron encoded reporter transcripts for minimally invasive monitoring of coding and non-coding RNAs
- 01-01011Biphasic, copolymeric, stretchable membrane and bioreactor for investigating cells at the air liquid interface (ALI)
- 01-01042
IDC-like 3D mammary organoids derived from healthy primary luminal cells with invasive potential
- 01-01045
Ex vivo method for determination of oxidative stress and diagnosis of ferroptosis-associated diseases
- 02-00116New viral packaging cell line
- 02-00353
High-throughput Screening for anti-herpesviridae Drugs
- 02-00369
Biodynamers enhance drug delivery
- 02-00380
Prediction for targeting efficiency of guide RNA for a gene of interest in bacteria
- 03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
- 03-00384
Short Term Isotope Pulse Labeling Method for Analyzing Metabolic States and Drug Targets in Biological Samples
- 03-00390
Genome Architecture Mapping (GAM)
- 03-00399/32-00019
Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00453
Homology Independent Genomic Sequence Replacement
- 03-00459
Autofocus-control of a microscope including an electrically tunable lens
- 03-00461
Identifying Cellular States and Fate Transitions via Synthetic Locus Control Regions (sLCRs)
- 03-00462
3D-Seq: Localizing Spatial Gene Expression in 3-Dimensions on Single Cell-Level
- 03-00470
FLAM-Seq: Genome-wide full-length mRNA and poly(A)-tail sequencing
- 03-00471
A FRET-based method to measure seeding activity of misfolded protein species in complex biological samples
- 03-00515
HDLBP overexpression enhances protein production and secretion
- 03-00539Sleeping Beauty transposase variants with increased safety due to reduced half-life
- 07-00080Innovative plasmids and cells for SARS-CoV-2-specific research
- 11-00035Cell wall-less bacteria (L-forms) for high yield heterologous protein expression
- 11-00053High quality tubulin and microtubule-associated proteins: tau, MAP1 and MAP2 as research tools
- 11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
- 14-00013MAdL monoclonal antibody: A novel, highly specific and sensitive biomarker for adenocarcinomas of the lung
- 14-00022Man6P-specific single chain antibody fragment for detection of mucolipidosis and optimization of enzyme production for ERT
- 14-00142
Flow cytometric basophil activation test for automated, high-throughput allergy diagnostics
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00551
Automated production of cardiac organoids
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00101
High-level recombinant adeno-associated virus production
- 32-00124
TCR/CD3-specific CAR NK-92 cells for purification of TCR-modified T cell products
- 40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects
- 43-00004
CRISPR Switch: Inducible sgRNA expression for tightly regulated, efficient and safer CRISPR/Cas9 genome editing
- 43-00006Genetically engineered human 3D brain tumor models for disease modeling and compound evaluation
- 43-00013
CRISPR StAR: sgRNA expression vectors for reliable and reproducible in vivo screenings
- 43-00017
SCON – Artificial intron devoid of hypomorphic target gene effects for one-step generation of conditional animal models
- 44-00014
Unconventional T cell population as blood marker for Crohn's disease
- 99-00075
DNA hydrogels from linear building blocks
- 99-00160
E-Morph Assay – an innovative image-based phenotypic screening assay for estrogenic and anti-estrogenic activity
Software
- Ref-No.Technology
- 01-00366Human Voxel Models
- 02-00377Low Bandwidth Data Base Synchronization – LBDS
- 02-00380
Prediction for targeting efficiency of guide RNA for a gene of interest in bacteria
- 03-00431
CrispRGold - Design of efficient Crispr/Cas sgRNA sequences
- 11-00052KILAPE – Automated scaffolding and gap filling of large, complex genomes
- 11-00064
Lifespan predictor - Reliable deep learning tool for in vivo lifespan prediction
- 15-00420Improved method of quantitative magnetic resonance lung imaging using ventilation-weighted Fourier decomposition
- 15-00565
Time-efficient assessment of pulmonary function via CT with low radiation doses
- 32-00056
Non-invasive measurement of myocardial power
- 32-00058Blood transfusion safety system Cairos
- 32-00081
Non-invasive pressure gradient prediction for a cardiovascular narrowing
Technical Equipment
- Ref-No.Technology
- 01-01011Biphasic, copolymeric, stretchable membrane and bioreactor for investigating cells at the air liquid interface (ALI)
- 02-00329
PADFEX- A device for direct pathogen detection in filtered expirates
- 03-00384
Short Term Isotope Pulse Labeling Method for Analyzing Metabolic States and Drug Targets in Biological Samples
- 03-00459
Autofocus-control of a microscope including an electrically tunable lens
- 15-00490
Irradiation device and method for optical cochlear implants and laser surgery sytems
- 21-00019
Microelectrode array with combined optical stimulation
- 21-00031Wireless Miniature Microscope For Near-Field Image-Capturing
- 21-00032
“Multiplextrode” – a completely novel electrode for analogue multiplexing
- 32-00030Method and arrangement for identification and correction of optical aberrations
- 32-00058Blood transfusion safety system Cairos
- 32-00108
Fiber Membrane Oxygenator with Minimized Priming Volume
Therapeutics
- Ref-No.Technology
- 01-00987
DMD Gene Therapy Approach
- 01-01015
AAV-based split-dCas9 gene activator system for in vivo reprogramming approaches
- 01-01080
Drug combinations to overcome therapy resistance in cancer
- 01-01085
Expansion of pancreatic progenitors derived from human pluripotent stem cells und GMP-compliant conditions
- 02-00311Cystobactamids – novel antibacterials against gram-negative pathogens
- 02-00315Novel Chelocardin Derivatives – resistance breaking atypical tetracyclines with broad-spectrum antibiotic activity
- 02-00316Innovative Inhibitors of Pseudomonas Pathogenicity
- 02-00332Novel inhibitors of Pseudomonas aeruginosa LecB
- 02-00337Novel labyrinthopeptins as anti-viral agents
- 02-00350Novel Ratjadones as payloads in folate-, peptide-, and antibody-drug conjugates for the treatment of cancer
- 02-00351Increased Availability and Efficacy of Aminoglycosides
- 02-00353
High-throughput Screening for anti-herpesviridae Drugs
- 02-00354Highly active Chlorotonil A Derivatives for the treatment of Malaria
- 02-00368Bivalent LecA Inhibitors Targeting Biofilm Formation of Pseudomonas aeruginosa
- 02-00369
Biodynamers enhance drug delivery
- 02-00373Highly potent small molecules prevent tissue damage following S. aureus infection by inhibiting α-hemolysin
- 02-00376
Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases
- 02-00378
Overcoming resistance - Novel inhibitors of virulence factor LasB of Pseudomonas aeruginosa
- 02-00385Next-Generation Probiotics
- 02-00386
Inhibitors of aconitate decarboxylase 1 – A novel immuno-therapeutic target
- 02-00387
Novel Darobactin Derivatives - highly active antibacterials against gram-negative bacteria
- 02-00396
Novel lectin-targeting conjugates for treatment or diagnosis of bacterial infections
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
- 03-00248
MAS-G-Protein-coupled receptor agonists for the treatment of the metabolic syndrome
- 03-00251
Stable Gene Transfer with Hyperactive Sleeping Beauty Transposase SB100X
- 03-00319
Stimulation of arteriogenesis for the prevention of myocardial infarction
- 03-00352
Repurposing Niclosamide for (neo-)adjuvant cancer therapy
- 03-00363
Small molecule inhibitors of STOML3 promise to treat neuropathic pain
- 03-00367Targeting of Autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer’s and vascular dementia
- 03-00393
Novel TPH inhibitors for the treatment of fibrotic diseases and pulmonary arterial hypertension (PAH)
- 03-00397
Plasma cell-specific antibodies targeting BCMA for the treatment of multiple myeloma and autoimmune diseases
- 03-00399/32-00019
Human satellite cells as cell therapy for the treatment of muscle waisting disorders
- 03-00413
Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4
- 03-00417
Novel BCMA-CAR for the treatment of multiple myeloma and non-Hodgkin lymphoma (NHL)
- 03-00430
Selective Inhibitors of Genotoxic Stress Induced IKK/NFκB Pathways for Cancer Therapy
- 03-00446
Novel CAR-T against CXCR5 for treatment of non-Hodgkin lymphoma
- 03-00454
ACE2 Inhibitors for therapy of inflammatory skin diseases and stimulation of pigmentation
- 03-00475
Novel combination of inhibitors of WNT and MACC1 for cancer therapy
- 03-00481
Spacer-nick genome editing of hematopoietic stem and progenitor cells and T cells
- 03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 10-00026Novel Benzothiazinones, potent Tuberculosis antibiotics
- 10-00087Jagaricin – a novel antifungal natural compound
- 10-00115Probiotics for Cancer Treatment
- 11-00057Innovative Nerve Sheath Tumor Therapy
- 11-00060
Novel treatment or prevention of age-related diseases extending lifespan
- 11-00065
Nutritional compositions for treating dysfunction of liver fat metabolism – VAFD
- 14-00020
Anti-inflammatory, LPS-neutralizing and anti-bacterial agent against sepsis and other severe bacterial infections
- 14-00020bSALP peptides are potent broad-spectrum anti-viral agents
- 14-00097
Antimicrobial, endotoxine-neutralizing and anti-inflammatory agent for wound healing and treatment of bacterial skin and soft-tissue infections
- 15-00371
lncRNAs in therapy and diagnosis of disease related angiogenesis
- 15-00436MicroRNA-125b-5p – a new treatment option for drug induced Acute Liver Failure
- 15-00446
Liver stem cell generation for therapeutic applications
- 15-00461
The physiological breast-milk proteins S100A8 and S100A9 promote an eubiotic gut state in infants
- 15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00611Engineered Immune Cells to Specifically Eliminate Undesired Immune Responses
- 15-00612TCR-agnostic identification of tumor-specific T cells for cancer diagnostics and therapy
- 15-00694
HLA-DR-specific γδ T-cell receptor to treat proliferative disorders of HLA-DR+ cells
- 18-00050
Lonafarnib inhibits cell entry of Human Respiratory Syncytial Virus (hRSV)
- 21-00019
Microelectrode array with combined optical stimulation
- 21-00027
Ferulic acid derivatives as efficient neuroprotective agent and memory enhancer
- 22-00009Quiescent B Cells for immune suppression in gene therapy
- 22-00017Functional IFN-gamma memory in CD4+ T cells: Method for improved T cell therapy and disease monitoring in autoimmune diseases
- 22-00020Bispecific antibodies for cell-type-specific TNF inhibition
- 23-00046
microRNA Signature Indicates Risk for Cognitive Decline
- 23-00064Treating dementia and other brain disorders with natural glycans
- 23-00065Novel treatment of dementia-associated tauopathies
- 23-00069
NMDAR targeted CAAR-T cell therapy
- 23-00075
HERV inhibitors for use in tauopathies
- 32-00059
T-cell therapy of MYD88L265P-dependent B-cell lymphoma
- 32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
- 32-00082
Reprogramming immune cells to develop allogenic CAR cell-based therapies
- 32-00083
CRISPR-Cas induced immunosuppressant resistance in anti-viral T cell products for clinical application
- 32-00101
High-level recombinant adeno-associated virus production
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 42-00040
Otviciclib - a new pan-CDK inhibitor in oncology
- 42-00047
Tyrolian algae extract with anti-inflammatory potential
- 44-00013
Keratinophile photosensitizers for safe and rapid treatment of onychomycosis
- 49-00012
A novel approach for acute leukocyte mobilization from the bone marrow
Vaccines
- Ref-No.Technology
- 02-00116New viral packaging cell line
- 02-00158
Cyclic di-Nucleotides as adjuvants
- 02-00160Hexosylceramides as adjuvants
- 02-00280Innovative lipopeptide-conjugates as mucosal adjuvants - BPPcysPep-MPEG
- 02-00361
Cyclic-di-AMP: a promising adjuvant for neonatal vaccines
- 02-00369
Biodynamers enhance drug delivery
- 02-00374
Phytosphingosine Derivatives as Adjuvants in Immune Stimulation
- 02-00393
REVERSE EPITOMICS BASED IDENTIFICATION OF ANTIGENIC PATCHES FOR IMMUNOGENIC COMPOSITIONS
- 02-00397
Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)
- 14-00176
Efficient, adjuvant-free mucosal vaccination via IgA feedback loop
- 15-00514
LS-COAT – an exceptionally efficient tumor vaccination approach
- 15-00527New Class of Bacterial Capsule Polymerases for Cost-Effective Synthesis of Glycoconjugate Vaccines
- 15-00601
Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis
- 23-00074Treating C9orf72 ALS/FTD with active vaccination
- 32-00135
Novel broad spectrum SARS-CoV-2 Vaccine Gene